OptimizeRx Corp (OPRX) stock

OPRXNasdaqServices-Business Services, NECFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 11/3030% below fair value

$7.34−1.53 (-17.25%)

Close on Nov 13, 2026Market cap $138.26MP/E 28.2Yield –

OptimizeRx EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

OptimizeRx's EV/EBITDA was 10.7× on Nov 11, 2026, against 26.3× a year earlier. Over the last 4 years it ranged from 5.4× to 973.3×, with a median of 93.7×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	10.7×	−10.5
2025	Dec 31, 2025	21.2×	−158.2
2022	Apr 29, 2022	179.4×	−747.2
2021	Dec 31, 2021	926.6×	+849.8
2020	Feb 28, 2020	76.8×	−8.4
2019	Dec 31, 2019	85.2×	−259.9
2018	Dec 31, 2018	345.1×	+283.0
2016	Jan 29, 2016	62.1×	−10.9
2015	Dec 31, 2015	73.0×	−20.7
2014	Jan 31, 2014	93.7×	+8.6
2013	Dec 31, 2013	85.1×	–